Pentosan Polysulfate Sodium
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00686 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 74 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | primary release disorder of platelets | KG + DL |
| 2 | Glanzmann thrombasthenia | KG + DL |
| 3 | pseudo-von Willebrand disease | KG + DL |
| 4 | fetal and neonatal alloimmune thrombocytopenia | KG + DL |
| 5 | autosomal dominant macrothrombocytopenia | KG + DL |
| 6 | hemoglobinopathy | KG + DL |
| 7 | autoimmune hemolytic anemia | KG + DL |
| 8 | autoimmune thrombocytopenic | KG + DL |
| 9 | bleeding diathesis due to a collagen receptor defect | KG + DL |
| 10 | hemorrhagic disorder due to a constitutional thrombocytopenia | KG + DL |
| 11 | rheumatoid arthritis | KG + DL |
| 12 | platelet-type bleeding disorder | KG + DL |
| 13 | acquired aplastic anemia | KG + DL |
| 14 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 15 | penile fibromatosis | KG + DL |
| 16 | disorder of GPI anchor biosynthesis | KG + DL |
| 17 | beta-thalassemia with other manifestations | KG + DL |
| 18 | bone Paget disease | KG + DL |
| 19 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 20 | renal osteodystrophy | KG + DL |
| 21 | pyropoikilocytosis, hereditary | KG + DL |
| 22 | Scott syndrome | KG + DL |
| 23 | Ledderhose disease | KG + DL |
| 24 | psoriasis | KG + DL |
| 25 | hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency | KG + DL |
| 26 | Ehlers-Danlos syndrome, fibronectinemic type | KG + DL |
| 27 | hemoglobinuria | KG + DL |
| 28 | infantile digital fibromatosis | KG + DL |
| 29 | palmar fibromatosis | KG + DL |
| 30 | brachydactyly-syndactyly syndrome | KG + DL |
| 31 | thrombotic thrombocytopenic purpura | KG + DL |
| 32 | pyruvate kinase deficiency of red cells | KG + DL |
| 33 | Gaisbock syndrome | KG + DL |
| 34 | coronary thrombosis | KG + DL |
| 35 | dermatitis herpetiformis | KG + DL |
| 36 | pityriasis lichenoides | KG + DL |
| 37 | hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency | KG + DL |
| 38 | thrombocytopenia due to immune destruction | KG + DL |
| 39 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 40 | scalp dermatosis | KG + DL |
| 41 | gout | KG + DL |
| 42 | impaired renal function disease | KG + DL |
| 43 | bone remodeling disease | KG + DL |
| 44 | hereditary thrombophilia due to congenital protein S deficiency | KG + DL |
| 45 | non-renal secondary hyperparathyroidism | KG + DL |
| 46 | neonatal thrombocytopenia | KG + DL |
| 47 | inherited thrombophilia | KG + DL |
| 48 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 49 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 50 | sickle cell-hemoglobin c disease syndrome | KG + DL |
(Showing top 50 of 74 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.